FDA Recalls MICON Antifungal Drugs for Improper Storage Conditions
Family Dollar Stores is recalling READY IN CASE MICON 7 DAY and 3 DAY COMBO PACK products distributed April 30 through June 10, 2022, because they were stored outside appropriate temperature conditions. Consumers should stop using these products and return them to Family Dollar.
What this means for you
Minor labeling or packaging issue, or a voluntary precautionary recall. Risk of harm is low but real — follow the manufacturer's instructions.
Our severity reasoning: This is an FDA Class II recall without any reported illnesses, injuries, or hospitalizations. The hazard is a storage temperature deviation that may affect drug potency and quality, making this a precautionary handling/quality recall rather than an imminent safety threat.
Plain-English summary
Family Dollar Stores, LLC, is recalling READY IN CASE MICON 7 DAY 1.59 OZ (SKU 939212) and READY IN CASE MICON 3 DAY COMBO PACK (SKU 902373) that were distributed to select Family Dollar Store locations from April 30, 2022, through June 10, 2022.
The recalled products were stored outside appropriate temperature conditions, which constitutes a Current Good Manufacturing Practice (CGMP) deviation. Improper storage conditions may compromise the integrity and effectiveness of the medication.
Consumers who purchased these products should discontinue use. The products may be returned to Family Dollar Stores for a refund. For questions regarding this recall, consumers can contact Family Dollar or the FDA.
The recalled product
- Product
- READY IN CASE MICON 7 DAY 1.59 OZ SKU 939212 READY IN CASE MICON 3 DAY COMBO PACK SKU 902373 distributed to specific Family Dollar Stores 04/30/2022 through 06/10/2022.
- Manufacturer
- Family Dollar Stores, Llc.
- Category
- Drug — Antifungal
- Hazard
- improper-storage
- cgmp-violation
Is your product affected?
Check your packaging against the codes below. If any of them match, the product is part of this recall.
Lot numbers (2)
- SKUs: 939212
- 902373
Distribution
Distributed nationwide across the United States.
Related recalls
Same category
- CriticalWarfarin Tablets Recalled After Mix-Up Between 2.5 mg and 5 mg Strengths
FDA (Drugs) · 2026-07-21
- ModerateFDA Recalls Pred Mild Ophthalmic Suspension Due to Failed Stability Specifications
FDA (Drugs) · 2026-06-03
- ModerateNicotine Transdermal System Patches Recalled for Oxidative Impurity Specification Failure
FDA (Drugs) · 2026-06-03
- LowPrimidone Tablets Recalled Due to Cross-Contamination with Acemetacin
FDA (Drugs) · 2026-05-27
- HighLiraglutide Injection Recalled Due to Particulate Matter in Cartridges
FDA (Drugs) · 2026-05-27